# MoonLake Immunotherapeutics: Form 8-K, filed Jun 6, 2025

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 16:30 ET
- Period: 2025-06-05
- Accession: 0001213900-25-052140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390025052140/ea0245015-8k_moonlake.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390025052140/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390025052140/ea0245015-8k_moonlake.htm

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-052140. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
